Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort
- 1 May 2019
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 112, 38-46
Abstract
No abstract availableKeywords
Funding Information
- Institut National Du Cancer
- Novartis
- Roche
This publication has 35 references indexed in Scilit:
- Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncologyJournal of Cancer Research and Clinical Oncology, 2013
- Ipilimumab and radiation therapy for melanoma brain metastasesCancer Medicine, 2013
- Predictive Factors for the Development of Brain Metastasis in Advanced Unresectable Metastatic MelanomaAmerican Journal of Clinical Oncology, 2011
- Outcome predictors of Gamma Knife surgery for melanoma brain metastasesJournal of Neurosurgery, 2011
- Prognostic factors for survival in melanoma patients with brain metastasesCancer, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Use of Magnetic Resonance Imaging to Assess Blood-Brain/Blood-Glioma Barrier Opening During Conformal RadiotherapyJournal of Clinical Oncology, 2005
- Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative studyStatistics in Medicine, 2004
- Adjusted survival curves with inverse probability weightsComputer Methods and Programs in Biomedicine, 2004
- Determinants of Outcome in Melanoma Patients With Cerebral MetastasesJournal of Clinical Oncology, 2004